However, the above-linked study doesn't appear to be published in any peer-reviewed journals
Unlike current GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy), Retatrutide is a triple hormone receptor agonistactivating GLP-1, GIP, and glucagon receptors simultaneously
The most common side effects in the trial included: Nausea (about 29 to 42 percent of participants, depending on the dose) Diarrhea (25 to 34 percent) Constipation (24 to 26 percent) Vomiting (11 to 25 percent) Upper respiratory tract infection (12 to 14 percent) These side effects are consistent with other injectable weight loss medications, according to Siegel
Why the Price of Weight Loss Medications is a Problem Another factor that complicates insurance coverage for weight loss medications is the high cost of these drugs
How should retatrutide be stored?+ Reconstitute the lyophilised powder with bacteriostatic water, store refrigerated (28C), and use within roughly four weeks